Strata Critical Medical, Inc. Acquires Keystone Perfusion Services, LLC

Strata Critical Medical, Inc. (the 'Company') has entered into a Purchase and Sale Agreement to acquire all of the issued and outstanding equity interests of Keystone Perfusion Services, LLC ('Keystone'), an organ recovery and normothermic regional perfusion service provider. The acquisition closed on September 16, 2025, with an aggregate consideration of $124 million, subject to adjustments, payable 80% in cash and 20% in shares of the Company’s common stock. Additionally, up to $23 million in contingent consideration may be paid based on Keystone’s financial performance over the next three years. The Purchase Agreement includes customary representations, warranties, and covenants, and the Company has obtained representation and warranty insurance. The acquisition is expected to enhance the Company’s service offerings in the transplant industry.